Dr. Stabler is an Associate Professor of Molecular Bacteriology in the Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine (LSHTM), where he has been a member of faculty since 2004. A specialist in bacterial genomics, antimicrobial resistance (AMR), and pathogen evolution, Dr. Stabler’s research spans fundamental microbiology, global health, and translational applications aimed at combatting drug-resistant infections.

Dr. Stabler earned his B.Sc. (Honours) in Applied Biology from the University of East London in 1995, followed by a Ph.D. in Molecular Bacteriology from the University of London in 2001. He later completed a Postgraduate Diploma at LSHTM in 2003. He began his research career as a Postdoctoral Research Scientist with the Bacterial Microarray Group at St George’s Hospital Medical School, where he worked from 2001 to 2004, contributing to early applications of genomic technologies for studying bacterial pathogens.

Since joining LSHTM, Dr. Stabler has built an internationally recognised research portfolio, marked by major contributions to the understanding of Clostridium difficile, Campylobacter, Acinetobacter baumannii, and a range of Gram-negative and Gram-positive pathogens. His work integrates high-resolution genomics, molecular microbiology, and applied epidemiology to investigate pathogen transmission, virulence, and antimicrobial resistance mechanisms. He has authored more than 100 peer-reviewed publications and has accumulated over 8,500 citations.

Dr. Stabler has served as Principal Investigator or Co-Investigator on numerous major grants from UKRI, MRC, the Fleming Fund, the European Space Agency, and international partners. Recent projects include leadership of the Fleming Fund Fellowships Phase II (£1.3M), contributions to monoclonal antibody development for drug-resistant Acinetobacter infections (£1.5M), and participation in the £20M GCRF One Health Poultry Hub. His funding portfolio reflects a broad engagement with global AMR challenges—from environmental reservoirs and livestock production to clinical diagnostics and novel therapeutics.

Demonstrating a strong commitment to academic leadership and capacity strengthening, Dr. Stabler founded and directed the LSHTM Antimicrobial Resistance Centre (2016–2021) and served as Programme Director for the LSHTM MSc in Medical Microbiology (2016-2025. He has supervised multiple doctoral students, acted as examiner for Ph.D. and M.Phil degrees, and contributes extensively to teaching in bacteriology and AMR.

Across his career, Dr. Stabler has combined molecular innovation with global health impact, advancing the scientific basis for tackling antimicrobial resistance